Skip to main content
Erschienen in: Archives of Dermatological Research 5/2017

12.04.2017 | Original Paper

Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees

verfasst von: N. Zander, I. Schäfer, M. Radtke, A. Jacobi, H. Heigel, M. Augustin

Erschienen in: Archives of Dermatological Research | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

The field of dermatological comorbidity in psoriasis is only passively explored with contradictory results. Objective of this study was to further investigate the complex field of psoriasis and associated skin diseases by identifying skin comorbidity patterns in an extensive cohort of employees in Germany. Retrospective analysis of data deriving from occupational skin cancer screenings was conducted. From 2001 to 2014 German employees between 16 and 70 years from different branches underwent single whole-body screenings by trained dermatologists in their companies. All dermatological findings and need for treatment were documented. Point prevalence rates and their 95% confidence intervals were computed. Logistic regression analysis was performed to calculate odds ratios (OR) of single dermatological diseases to occur together with psoriasis controlled for age and sex. Data from 138,930 persons (56.5% male, mean age 43.2) were evaluated. Psoriasis point prevalence was 2.0%. Of those 20.6% had unmet treatment needs of their disease. Onychomycosis was the most frequent dermatological comorbidity with a prevalence of 7.8%. Regression analysis found rosacea (OR = 1.40, 95% CI 1.13–1.72) and telangiectasia (OR = 1.25, 95% CI 1.10–1.41) to be significantly associated with psoriasis. 17.2% of psoriasis patients had at least one further finding requiring treatment. The highest treatment needs were found for onychomycosis (3.4%), tinea pedis (3.1%), and verruca plantaris (1.0%). It can be concluded that persons with psoriasis are at increased risk to suffer from comorbid skin diseases, which should be considered in treatment regimens. Particular attention should be paid to fungal diseases of the feet.
Literatur
1.
Zurück zum Zitat Alteras I, Ingberg A, Segal R et al (1986) The incidence of skin manifestations by dermatophytes in patients with psoriasis. Mycopathologia 95(1):37–39CrossRefPubMed Alteras I, Ingberg A, Segal R et al (1986) The incidence of skin manifestations by dermatophytes in patients with psoriasis. Mycopathologia 95(1):37–39CrossRefPubMed
2.
Zurück zum Zitat Altunay ZT, Ilkit M, Denli Y (2009) Psöriazisli olgularda tinea pedis ve ayak tirnaği onikomikozu prevalansinin araştirilmasi. Mikrobiyol Bul 43(3):439–447PubMed Altunay ZT, Ilkit M, Denli Y (2009) Psöriazisli olgularda tinea pedis ve ayak tirnaği onikomikozu prevalansinin araştirilmasi. Mikrobiyol Bul 43(3):439–447PubMed
3.
Zurück zum Zitat Arunachalam M, Dragoni F, Colucci R et al (2014) Non-segmental vitiligo and psoriasis comorbidity—a case-control study in Italian patients. J Eur Acad Dermatol Venereol 28(4):433–437CrossRefPubMed Arunachalam M, Dragoni F, Colucci R et al (2014) Non-segmental vitiligo and psoriasis comorbidity—a case-control study in Italian patients. J Eur Acad Dermatol Venereol 28(4):433–437CrossRefPubMed
4.
Zurück zum Zitat Augustin M, Glaeske G, Radtke M et al (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162(3):633–636CrossRefPubMed Augustin M, Glaeske G, Radtke M et al (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162(3):633–636CrossRefPubMed
5.
Zurück zum Zitat Augustin M, Krüger K, Radtke M et al (2008) Disease severity, quality of life and health care in plaque-type psoriasis: a Multicenter Cross-Sectional Study in Germany. Dermatology 216(4):366–372CrossRefPubMed Augustin M, Krüger K, Radtke M et al (2008) Disease severity, quality of life and health care in plaque-type psoriasis: a Multicenter Cross-Sectional Study in Germany. Dermatology 216(4):366–372CrossRefPubMed
6.
Zurück zum Zitat Augustin M, Reich K, Glaeske G et al (2010) Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 90(2):147–151CrossRefPubMed Augustin M, Reich K, Glaeske G et al (2010) Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 90(2):147–151CrossRefPubMed
7.
Zurück zum Zitat Augustin M, Schäfer I, Reich K et al (2011) Systemic treatment with corticosteroids in psoriasis–health care provision far beyond the S3-guidelines. J Dtsch Dermatol Ges 9(10):833–838PubMed Augustin M, Schäfer I, Reich K et al (2011) Systemic treatment with corticosteroids in psoriasis–health care provision far beyond the S3-guidelines. J Dtsch Dermatol Ges 9(10):833–838PubMed
9.
Zurück zum Zitat Blome C, Simianer S, Purwins S et al (2010) Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology 221(2):154–159CrossRefPubMed Blome C, Simianer S, Purwins S et al (2010) Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology 221(2):154–159CrossRefPubMed
10.
Zurück zum Zitat Boehncke W-H, Boehncke S (2012) Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep 14(4):343–348CrossRefPubMed Boehncke W-H, Boehncke S (2012) Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep 14(4):343–348CrossRefPubMed
11.
12.
Zurück zum Zitat Eisen EA, Picciotto S, Robins JM (2013) Healthy worker effect. In: El-Shaarawi AH, Piegorsch WW (eds) Encyclopedia of environmetrics, 3rd edn. Wiley Eisen EA, Picciotto S, Robins JM (2013) Healthy worker effect. In: El-Shaarawi AH, Piegorsch WW (eds) Encyclopedia of environmetrics, 3rd edn. Wiley
13.
Zurück zum Zitat Eissing L, Radtke MA, Zander N et al (2016) Barriers to guideline-compliant psoriasis care: analyses and concepts. J Eur Acad Dermatol Venereol 30(4):569–575CrossRefPubMed Eissing L, Radtke MA, Zander N et al (2016) Barriers to guideline-compliant psoriasis care: analyses and concepts. J Eur Acad Dermatol Venereol 30(4):569–575CrossRefPubMed
15.
Zurück zum Zitat Hamnerius N, Berglund J, Faergemann J (2004) Pedal dermatophyte infection in psoriasis. Br J Dermatol 150(6):1125–1128CrossRefPubMed Hamnerius N, Berglund J, Faergemann J (2004) Pedal dermatophyte infection in psoriasis. Br J Dermatol 150(6):1125–1128CrossRefPubMed
16.
Zurück zum Zitat Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982–986CrossRefPubMed Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982–986CrossRefPubMed
17.
Zurück zum Zitat Klaassen KMG, Dulak MG, van de Kerkhof PCM et al (2014) The prevalence of onychomycosis in psoriatic patients: a systematic review. J Eur Acad Dermatol Venereol 28(5):533–541CrossRefPubMed Klaassen KMG, Dulak MG, van de Kerkhof PCM et al (2014) The prevalence of onychomycosis in psoriatic patients: a systematic review. J Eur Acad Dermatol Venereol 28(5):533–541CrossRefPubMed
18.
Zurück zum Zitat Kragballe K, Austad J, Barnes L et al (2006) A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of Psoriasis vulgaris. Br J Dermatol 154(6):1155–1160CrossRefPubMed Kragballe K, Austad J, Barnes L et al (2006) A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of Psoriasis vulgaris. Br J Dermatol 154(6):1155–1160CrossRefPubMed
19.
Zurück zum Zitat Lebwohl MG, Bachelez H, Barker J et al (2014) Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol 70(5):871–881.e1–30CrossRefPubMed Lebwohl MG, Bachelez H, Barker J et al (2014) Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol 70(5):871–881.e1–30CrossRefPubMed
20.
Zurück zum Zitat Leibovici V, Ramot Y, Siam R et al (2014) Prevalence of tinea pedis in psoriasis, compared to atopic dermatitis and normal controls–a prospective study. Mycoses 57(12):754–758CrossRefPubMed Leibovici V, Ramot Y, Siam R et al (2014) Prevalence of tinea pedis in psoriasis, compared to atopic dermatitis and normal controls–a prospective study. Mycoses 57(12):754–758CrossRefPubMed
21.
Zurück zum Zitat Meyer-Hoffert U (2009) Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp 57(5):345–354CrossRef Meyer-Hoffert U (2009) Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp 57(5):345–354CrossRef
22.
Zurück zum Zitat Montaudié H, Albert-Sabonnadière C, Acquacalda E et al (2014) Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol 28(9):1186–1191CrossRefPubMed Montaudié H, Albert-Sabonnadière C, Acquacalda E et al (2014) Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol 28(9):1186–1191CrossRefPubMed
23.
Zurück zum Zitat Nast A, Boehncke W-H, Mrowietz U et al (2012) S3—guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges 10(Suppl 2):S1–S95CrossRef Nast A, Boehncke W-H, Mrowietz U et al (2012) S3—guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges 10(Suppl 2):S1–S95CrossRef
25.
Zurück zum Zitat Paquet P, Claessens N, Piérard-Franchimont C et al (2005) Effets cutanés indésirables du lithium. Rev Med Liege 60(11):885–887PubMed Paquet P, Claessens N, Piérard-Franchimont C et al (2005) Effets cutanés indésirables du lithium. Rev Med Liege 60(11):885–887PubMed
26.
Zurück zum Zitat Parisi R, Symmons DP, Griffiths CE et al (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Investig Dermatol 133(2):377–385CrossRefPubMed Parisi R, Symmons DP, Griffiths CE et al (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Investig Dermatol 133(2):377–385CrossRefPubMed
27.
Zurück zum Zitat Poljacki M, Begenesić M, Duran V et al (2002) Psorijaza i oboljenja koze autoimunske prirode. Med Pregl (Medicinski pregled) 55(7–8):325–328CrossRef Poljacki M, Begenesić M, Duran V et al (2002) Psorijaza i oboljenja koze autoimunske prirode. Med Pregl (Medicinski pregled) 55(7–8):325–328CrossRef
28.
Zurück zum Zitat Radtke MA, Reich K, Blome C et al (2009) Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 23(6):683–691CrossRefPubMed Radtke MA, Reich K, Blome C et al (2009) Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 23(6):683–691CrossRefPubMed
29.
Zurück zum Zitat Radtke MA, Schafer I, Glaeske G et al (2016) Prevalence and comorbidities in adults with psoriasis compared to atopic eczema. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.13813 Radtke MA, Schafer I, Glaeske G et al (2016) Prevalence and comorbidities in adults with psoriasis compared to atopic eczema. J Eur Acad Dermatol Venereol. doi:10.​1111/​jdv.​13813
30.
Zurück zum Zitat Rapp S, Feldmann S, Exum M et al (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401–407CrossRefPubMed Rapp S, Feldmann S, Exum M et al (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401–407CrossRefPubMed
31.
Zurück zum Zitat Reich A, Hrehorów E, Szepietowski JC (2010) Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 90(3):257–263CrossRefPubMed Reich A, Hrehorów E, Szepietowski JC (2010) Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 90(3):257–263CrossRefPubMed
32.
Zurück zum Zitat Reich K (2012) The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 26(Suppl 2):3–11CrossRefPubMed Reich K (2012) The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 26(Suppl 2):3–11CrossRefPubMed
33.
Zurück zum Zitat Reich K, Krüger K, Mössner R et al (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160(5):1040–1047CrossRefPubMed Reich K, Krüger K, Mössner R et al (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160(5):1040–1047CrossRefPubMed
34.
Zurück zum Zitat Sawchuk M, Spano F, Loo WJ et al (2012) The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg 16(5):300–305CrossRefPubMed Sawchuk M, Spano F, Loo WJ et al (2012) The coexistence of psoriasis and vitiligo: a review. J Cutan Med Surg 16(5):300–305CrossRefPubMed
35.
Zurück zum Zitat Schaefer I, Rustenbach SJ, Zimmer L et al (2008) Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 217(2):169–172CrossRefPubMed Schaefer I, Rustenbach SJ, Zimmer L et al (2008) Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 217(2):169–172CrossRefPubMed
36.
Zurück zum Zitat Schäfer I, Rustenbach SJ, Radtke M et al (2011) Epidemiologie der Psoriasis in Deutschland-Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung. Gesundheitswesen 73(5):308–313CrossRefPubMed Schäfer I, Rustenbach SJ, Radtke M et al (2011) Epidemiologie der Psoriasis in Deutschland-Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung. Gesundheitswesen 73(5):308–313CrossRefPubMed
38.
Zurück zum Zitat Schittek B, Paulmann M, Senyurek I et al (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8(3):135–143CrossRefPubMed Schittek B, Paulmann M, Senyurek I et al (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8(3):135–143CrossRefPubMed
39.
Zurück zum Zitat Schmid-Ott G, Malewski P, Kreiselmaier I et al (2005) Psychosocial consequences of psoriasis—an empirical study on the burden of skin disease in 3753 patients. Hautarzt 56(5):466–472CrossRefPubMed Schmid-Ott G, Malewski P, Kreiselmaier I et al (2005) Psychosocial consequences of psoriasis—an empirical study on the burden of skin disease in 3753 patients. Hautarzt 56(5):466–472CrossRefPubMed
40.
Zurück zum Zitat Sheth VM, Guo Y, Qureshi AA (2013) Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology 227(4):311–315CrossRefPubMed Sheth VM, Guo Y, Qureshi AA (2013) Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology 227(4):311–315CrossRefPubMed
41.
Zurück zum Zitat Shi VY, Leo M, Hassoun L et al (2015) Role of sebaceous glands in inflammatory dermatoses. J Am Acad Dermatol 73(5):856–863CrossRefPubMed Shi VY, Leo M, Hassoun L et al (2015) Role of sebaceous glands in inflammatory dermatoses. J Am Acad Dermatol 73(5):856–863CrossRefPubMed
42.
Zurück zum Zitat Ständer S, Schäfer I, Phan NQ et al (2010) Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 221(3):229–235CrossRefPubMed Ständer S, Schäfer I, Phan NQ et al (2010) Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 221(3):229–235CrossRefPubMed
43.
Zurück zum Zitat Szepietowski JC, Reich A, Garlowska E et al (2006) Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol 142(10):1279–1284CrossRefPubMed Szepietowski JC, Reich A, Garlowska E et al (2006) Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol 142(10):1279–1284CrossRefPubMed
45.
Zurück zum Zitat Yazici A, Akturk AS, Cefle A et al (2014) Rosacea associated with etanercept. Joint Bone Spine 81(3):274–275CrossRefPubMed Yazici A, Akturk AS, Cefle A et al (2014) Rosacea associated with etanercept. Joint Bone Spine 81(3):274–275CrossRefPubMed
46.
Zurück zum Zitat Yeung CK, Chan HHL (2004) Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol 5(1):3–8CrossRefPubMed Yeung CK, Chan HHL (2004) Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol 5(1):3–8CrossRefPubMed
48.
Zurück zum Zitat Zhu K-J, Lv Y-M, Yin X-Y et al (2011) Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS One 6(11):e23089CrossRefPubMedPubMedCentral Zhu K-J, Lv Y-M, Yin X-Y et al (2011) Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS One 6(11):e23089CrossRefPubMedPubMedCentral
Metadaten
Titel
Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees
verfasst von
N. Zander
I. Schäfer
M. Radtke
A. Jacobi
H. Heigel
M. Augustin
Publikationsdatum
12.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 5/2017
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-017-1741-4

Weitere Artikel der Ausgabe 5/2017

Archives of Dermatological Research 5/2017 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.